Furthermore, in a study performed on a rotenone (ROT) induced rat model of PD, apigenin significantly reduced the expression and aggregation of α-synuclein and increased the expression of dopamine D2 receptor (D2R) compared to control rats treated with ROT [105]. This evidence concerns the gene DRD2 and Parkinson disease.